Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications

To examine the geographic and pharmacy-type variation in costs for generic benign prostatic hyperplasia (BPH) medications in order to improve drug price transparency and reduce health disparities. Medical therapy for BPH can be expensive, having significant implications for uninsured and underinsured patients.

Source: Urology - September 18, 2020 Category: Urology & Nephrology Authors: Anup A. Shah, Praveen Kumar, Ayodele G. Ogunmola, Omar Ayyash, Jonathan G. Yabes, Lindsay M. Sabik, Anobel Y. Odisho, Jathin Bandari, Liam C. Macleod, Benjamin J. Davies, Bruce L. Jacobs Tags: Health Services Research Source Type: research